@nirdesh There was no difference in the primary endpoint components of operative mortality (2% methylprednisolone group vs 2.8% placebo), a composite of mortality and major complications (17.2% vs 20.3%), and prolonged mechanical ventilation (6.8% vs 8.5%).
Babies who received methylprednisolone were also more likely to have high blood glucose levels, a known stress response to surgery, with 19% requiring postoperative insulin vs 6.7% with placebo (P < .001), according to results published November 6 in the New England Journal of Medicine.